Back to Search
NANCY ANN SIMONIAN, M.D.
M.D.
Neurology Physician
NPI: 1386712123Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
76051(MA)
Research & Publications (13)
Glycoprotein IIb/IIIa inhibitor therapy and outcomes after percutaneous coronary intervention.
PMID 12972136·Am J Cardiol·2003
8-other
Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis.
PMID 12617260·Mult Scler·2003
3-trial
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
PMID 12221157·Neurology·2002
3-trial
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.
PMID 11902591·Neurology·2001
8-other
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
PMID 11405811·Arch Neurol·2001
3-trial
Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.
PMID 11376182·Neurology·2001
8-other
Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25).
PMID 11212133·Mult Scler·2000
4-observational
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients.
PMID 11212131·Mult Scler·2000
8-other
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.
PMID 11006365·N Engl J Med·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- MILLENNIUM PHARMACEUTICALS, 40 LANDSDOWNE ST
CAMBRIDGE, MA 02139 - Phone
- (617) 551-3612
Quick Facts
- NPI
- 1386712123
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile